Investegate |Telix Pharmaceuticals Limited Announcements | Telix Pharmaceuticals Limited: First Patient Dosed in ProstACT Program for Prostate Cancer Therapy
Investegate announcements from Telix Pharmaceuticals Limited, First Patient Dosed in ProstACT Program for Prostate Cancer Therapy
United States Kyahn Williamson Colin Hayward Kenneth Obyrne Telix Prost Unitedstatesandmaynotbeofferedorsoldwithintheunited States
Source: investegate.co.uk